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CREB Regulates MHC Class II Expression
in a CIITA-Dependent Manner
et al., 1996; Boss, 1997). Complementation studies, us-
ing cell lines derived from these patients, identified four
complementation groups (Benichou and Strominger,
Carlos S. Moreno,²³ Guy W. Beresford,²
Pascale Louis-Plence,§ Ann C. Morris,
and Jeremy M. Boss*
1991; Seidl et al., 1992). The genes defective in all ofDepartment of Microbiology and Immunology
these groups have been identified. The class II transacti-Emory University School of Medicine
vator (CIITA) complements BLS group A cell lines andEmory University
functions as a regulator of MHC class II transcriptionAtlanta, Georgia 30322
(Steimle et al., 1993). Although it does not bind to DNA,
CIITA possesses a potent transcriptional activation do-
main (Riley et al., 1995; Zhou and Glimcher, 1995). Based
Summary on genetic analysis and protein-DNA interactions, the
X box region was subdivided into adjacent subelements
The X2 box of MHC class II promoters is homologous termed the X1 and X2 boxes. The remaining three BLS
to TRE/CRE elements and is required for expression of complementation groups (B, C, and D) are each defec-
MHC class II genes. The X2 box-specific DNA binding tive for the DNA binding activity of the X1 box factor,
activity, X2BP, was purified to homogeneity, sequenced, RFX, suggesting that RFX consists of at least three sub-
and identified as CREB. Transient transactivation ex- units. Indeed, immunoprecipitaions of RFX contain three
periments showed that CREB can cooperate with proteins (Moreno et al., 1997), and genes that comple-
CIITA to enhance activation of transcription from MHC ment BLS groups C and D have been identified (Steimle
et al., 1995; Durand et al., 1997). The gene complement-class II promoters in a dose-dependent manner. Bind-
ing BLS group B cell lines has been recently cloned anding of CREB to the class II promoter in vivo was demon-
encodes a novel protein (Nagarajan et al., 1999).strated by a chromatin immunoprecipitation assay.
The X2 box is required for MHC class II expressionAdditionally, ICER, a dominant inhibitor of CREB func-
(Sloan et al., 1992) and is homologous to both cAMP andtion, was found to repress class II expression. These
TPA response elements, CRE and TRE, respectively.results demonstrate that CREB binds to the X2 box in
A number of bZip family members were identified byvivo and cooperates with CIITA to direct MHC class
screening libraries for X box binding proteins, includingII expression.
hXBP-1 (Liou et al., 1990; Ono et al., 1991b), mXBP-1
(Ivashkiv et al., 1990), c-jun (Andersson and Peterlin,
Introduction 1990), and c-fos (Ono et al., 1991a). However, none of
these candidate proteins were shown to bind to the X2
Major histocompatibility complex (MHC) class II anti- box of all class II genes or to be clearly responsible for
gens are a/b heterodimeric cell surface glycoproteins MHC class II expression. Using a biochemical approach,
that function to present processed antigens to CD41 T X2BP, an X2-specific binding protein, was identified in
lymphocytes (Unanue et al., 1989). The three isotypes nuclear extracts prepared from B cells (Hasegawa and
of the human MHC class II proteins, HLA-DR, -DQ, and Boss, 1991) and was linked to class II expression by the
-DP, are transcriptionally regulated by a set of con- discovery that it binds synergistically and cooperatively
served cis-acting DNA elements known as the W (or S), with purified RFX to the X boxes of all class II genes
X, and Y boxes (reviewed in Boss, 1997; Mach et al., (Moreno et al., 1995; Louis-Plence et al., 1997). Addition-
1996; Benoist and Mathis, 1990; Glimcher and Kara, 1992). ally, a quaternary complex consisting of the class II X-Y
Tissue specificity of MHC class II genes is restricted to DNA, RFX, X2BP, and the Y box factor NF-Y, formed in
a few types of immune cells including B lymphocytes, a quantitative manner. This RFX/X2BP/NF-Y/DNA com-
dendritic cells, activated T cells, macrophages, and thy- plex was extremely stable in vitro, having a half-life
mic epithelium. Additionally, transcription of MHC class greater than 4 hr (Louis-Plence et al., 1997). Together,
II genes may also be induced by interferon-g (IFNg) in these analyses provide compelling evidence that X2BP
many cell types (Collins et al., 1984; Basta et al., 1987), is the X2 box DNA binding protein required for class II
potentially allowing these cells to present antigens to T expression.
lymphocytes. Clues to the identity of X2BP were provided by an
Patients exhibiting the bare lymphocyte syndrome initial series of gel shift assays in which antisera to rat
(BLS), a severe congenital immunodeficiency, fail to ex- CREB was able to supershift X2BP-DNA complexes
press MHC class II genes due to mutations in transcrip- (Moreno et al., 1995). These studies suggested that
tion factors required for MHC class II expression (Mach X2BP or a subunit of X2BP was related to a CREB family
member. CREB is a transcription factor that was origi-
nally purified from rat liver nuclear extracts for its ability
* To whom correspondence should be addressed (e-mail: boss@ to activate the somatostatin gene in response to cAMP
microbio.emory.edu). (Montminy and Bilezikjian, 1987; Yamamoto et al., 1988).² These authors contributed equally to this work. In this system, CREB is induced to activate transcription³ Present address: Department of Biochemistry, Emory University,
when it is phosphorylated on a highly conserved serineAtlanta, Georgia 30322.
residue (Ser133 in mouse, Ser119 in humans). Phosphor-§ Present address: Laboratoire d'Immunologie-INSERM U475, HoÃ pi-
tal Saint-Eloi, 34 295 Montpelier cedex 5, France. ylation of Ser119 in the kinase inducible domain (KID)
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Figure 2. Amino Acid Sequence of Human CREB Matches with Mi-
crosequence Derived from X2BP Peptides
Internal amino acid microsequence matches to X2BP are shown in
bold. Mass spectrometry sequence matches with X2BP are under-
lined. Single amino acid mismatch from mass spectrometry data
with the human consensus sequence is indicated by a dashed line.
The N-terminal peptide used to generate the anti-CREB antisera is
shown in italics.
the X2 box factor that participates in the regulation of
MHC class II genes and suggest novel ways in which
immune responses may be controlled.
Results
X2BP Amino Acid Sequence Matches CREBFigure 1. Purification of X2BP
To identify the components of X2BP, X2BP was purified(A) Purification scheme for X2BP. (B) Silver stain of SDS-PAGE con-
taining DNA affinity-purified X2BP. The two proteins, migrating at from nuclear extracts prepared from 50 liters of Raji
120 and 46 kDa, were determined by amino acid sequence and B cells, using conventional chromatography, involving
mass spectrometry to be poly-ADP-ribose polymerase (PARP) and heparin agarose and HiTrap Q matricies (Moreno et al.,
CREB, respectively. (C) Autoradiograph of a Western blot of X-box
1995) and X box DNA affinity chromatography using aaffinity-purified X2BP and recombinant human CREB using a spe-
magnetic bead resin (Figure 1A). Purification was similarcific anti-CREB antisera show that this antisera recognizes purified
to that previously reported (Moreno et al., 1995) exceptX2BP.
that the use of the magnetic beads allowed more effi-
cient concentration of X2BP at the final step. Two pro-
teins were observed by silver staining the affinity purifiedenables CREB to interact with a coactivator known as
the CREB binding protein (CBP) (Gonzalez and Mont- X2BP that had molecular masses of 46 and 120 kDa
(Figure 1B). These proteins were digested with lysylen-miny, 1989; Chrivia et al., 1993). CBP interacts with the
general transcription factor TFIIB (Kwok et al., 1994) dopeptidase C and sequenced using Edman chemistry.
From the 46 kDa protein, the sequences of two peptidesand has an intrinsic enzymatic histone acetyltransferase
(HAT) activity that facilitates chromatin remodeling and were obtained that yielded a continuous 33 amino acid
sequence identical to the KID of human CREB (Figureactivation of transcription (Emery et al., 1996; Ogryzko
et al., 1996). 2). In addition, three separate peptides were identified
by mass spectrometry of an independent preparationHere, we report on the purification and identification of
X2BP. Microsequence and mass spectrometry analyses of the 46 kDa component of X2BP that also matched
human CREB. One peptide was identical to a portion ofdetermined that X2BP amino acid sequences match
those of CREB. To support this in vitro biochemical the N-terminal domain of CREB and partially overlapped
a peptide used to generate CREB antisera. The secondidentification, three lines of biological evidence demon-
strate that CREB is indeed the factor bound to the X2 peptide overlapped the KID region that was micro-
sequenced by Edman degradation. The third and mostbox of class II genes. First, transient transactivation ex-
periments showed that CREB can cooperate with CIITA C-terminal peptide had a single GluLys amino acid sub-
stitution at position 305 of the consensus human CREBto activate MHC class II expression. Second, a crosslink-
ing immunoprecipitation assay was used to demon- sequence. A similar K305 substitution was reported in
the D isoform of rat CREB (Short et al., 1991) and resultsstrate that CREB was bound to the class II promoter in
vivo. Third, we showed that a dominant negative inhibi- from a single G to A transition at position 913 of the
human CREB cDNA sequence. To determine if the K305tor of CREB activity, the inducible cAMP early repressor
(ICER), is able to repress transcription from MHC class polymorphism was present in Raji cells, RT-PCR was
performed with primers that contained either a C or T atII promoters. Together, these data implicate CREB as
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phosphorylated in vitro by PKA (compare lanes 1 and
3). Moreover, rCREB was able to form a complex on
X-box DNA with RFX similar to that formed previously
with X2BP (Figure 3, lanes 6 and 7). Together, these
data support the amino acid sequencing data and we
conclude that the factor previously referred to as X2BP
is CREB.
CREB Cooperates with CIITA To Activate MHC
Class II Transcription
To demonstrate a role for CREB in MHC class II expres-
sion, two experimental approaches were used. First,
the effect of exogenously provided CREB on class II
expression was determined in transient transfections,
and second, the ability of a dominant negative repressor
of CREB to downregulate class II expression was as-
sessed. Transient transactivation experiments were con-
ducted in the MHC class II negative murine embryonic
carcinoma F9 cell line (Figure 4). Because they appear
to be deficient for endogenous CREB activity, F9 cells
Figure 3. Recombinant CREB Forms a Complex with RFX on X Box
have been used to test CREB function. Moreover, exog-DNA
enously introduced CREB and PKA can activate theAutoradiograph of electrophoretic mobility shift assay (EMSA) using
somatostatin promoter in F9 cells (Gonzalez and Mont-purified X2BP (lane 1), recombinant CREB (lane 2), CREB phosphor-
miny, 1989; Yamamoto et al., 1990; Masson et al., 1992).ylated in vitro by PKA (lane 3), and partially purified RFX (lane 4).
Multifactor protein/DNA complexes were formed with purified X2BP F9 cells were cotransfected with vectors expressing
and RFX (lane 5), recombinant CREB and RFX (lane 6), and phos- CIITA (which is required for expression of class II genes
phorylated CREB and RFX (lane 7), as previously described (Louis- in F9 cells), CREB, a CAT reporter driven by the con-
Plence et al., 1997).
served WXY elements of the class II DRA gene promoter
(pDRCAT-WXY) and a constitutively expressed lucifer-
the most 3 base of the downstream primers. Preferential ase reporter. CREB activation was determined by mea-
amplification of the CREB sequence corresponding to suring CAT protein levels by ELISA. Cotransfection of
the K305 substitution was observed, confirming that this CREB with CIITA increased reporter expression in a
polymorphism is present in Raji cell DNA (data not dose-dependent manner (Figure 4A). The 5- to 6-fold
shown). Thus, the 46 kDa component of X2BP is identi- increase in transcription induced by the highest concen-
cal to CREB. The larger 120 kDa protein was positively tration of CREB was seen at a range of concentrations
identified by microsequencing with multiple sequence of CIITA. Transfection of CREB alone had no effect on
matches to be poly-ADP ribose polymerase (PARP), an transcription from the DRA promoter in the absence of
abundant DNA repair enzyme that binds to nicked DNA CIITA (Figure 4B). The dependence of this transactiva-
and appears to be a copurifying contaminant. tion on the WXY promoter elements was demonstrated
using the pDRCAT control reporter, which lacks these
Recombinant CREB Has the Same Biochemical sequences. No CAT activity was seen for cotransfec-
Activity as Purified X2BP tions using the control reporter with either CIITA, CREB
To confirm that CREB was part of X2BP, a separate or both (Figure 4B).
approach was taken. A polyclonal antisera specific to To determine if other bZip transcription factors, which
amino acids 5±45 of human CREB was generated (Figure bind to CRE sequences, could substitute for CREB in
2). This region of CREB does not exhibit high homology this system, vectors expressing ATF-1 and ATF-2 were
to other CREB/ATF family members, including the highly tested for their ability to stimulate CIITA and X box-
homologous family member, CREM. The anti-CREB dependent expression. No CAT protein was detected in
antisera specifically recognized bacterially produced transfections with ATF-1 or ATF-2 in the absence of
recombinant CREB (rCREB) by Western blot (Figure 1C) CIITA or in the absence of the WXY-containing reporter
but did not cross-react with CREM (data not shown). (Figure 4C). In the presence of the WXY-dependent re-
Moreover, this antisera recognized purified X2BP (Fig- porter, an increase in activity of less than 1.5-fold was
ure 1C) and supershifted X2BP-X box complexes in
noted for these transcription factors (Figure 4C). This
EMSAs (Louis-Plence et al., 1997). Furthermore, the
increase was independent of CIITA concentration (data
anti-CREB antisera supershifted X2BP-RFX/X box and
not shown). Thus, CREB but not ATF-1 or ATF-2 cooper-
X2BP-RFX-NFY/X-Y box protein-DNA complexes in
ates with CIITA to enhance the expression from the HLA-
vitro (Louis-Plence et al., 1997), demonstrating that
DRA promoter.
CREB forms a complex with factors known to be impor-
tant for class II expression in vivo.
ICER Can Repress Transcription from MHCTo determine if CREB could substitute for X2BP in in
Class II Promotersvitro assays, EMSAs were performed comparing X2BP
The second experimental approach used to demon-to rCREB (Figure 3). rCREB binding to the X box gener-
ated an EMSA pattern similar to X2BP, particularly when strate a role for CREB in MHC class II expression was to
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Figure 4. CREB Cooperates with CIITA To
Activate Transcription of the MHC Class II
DRA Promoter
F9 cells were cotransfected by electropora-
tion (300 V, 960 mF) with 0±30 mg of CIITA
(Riley et al., 1995), 10±40 mg of CREB (pRSV-
CREBWT) (Walton et al., 1992), and 2 mg of
luciferase reporter pGL3. Each transfection
used either 10 mg of the pDRCAT-WXY re-
porter construct (Hasegawa et al., 1993),
which contains the CAT gene fused to the
DRA promoter, or 10 mg of the pDRCAT re-
porter construct, which deletes the W, X, and
Y boxes. Levels were normalized to luciferase
activity to control for transfection efficiency.
Data shown are representative of at least
three separate and complete experiments. In
each case, the relative fold activation ob-
served was similar. (A) Dose response effect
of CREB on CIITA activation. (B) Effect of
CIITA and CREB on expression from the
pDRCAT-WXY and pDRCAT reporters. F9
cells were cotransfected with 30 mg CIITA
and/or 20 mg CREB. (C) Effect of CIITA,
ATF-1, and ATF-2 on expression from the
pDRCAT-WXY reporter. F9 cells were co-
transfected with 30 mg of pECE RSVATF-1 or
30 mg of pECE RSVATF-2 in the presence or
absence of 30 mg of CIITA.
determine the repressive effect of ICER on constitutively formaldehyde-treated cells with anti-acetylated H3 and
H4 histone antibodies (Kuo et al., 1998). We haveactive MHC class II expression. ICER, a protein derived
from a transcript that encodes only the DNA binding adopted this technique to show that CREB is associated
with the MHC class II X2 box in vivo. Chromatin wasand dimerization domains of CREM, represses CREB-
mediated transcription from CRE sites and is induced by prepared from Raji B cells that were crosslinked with
formaldehyde. After shearing the DNA into an averagecAMP (Molina et al., 1993). ICER can also heterodimerize
with CREB and is highly homologous (71% amino acid size of 600 base pairs, immunoprecipitations were per-
formed with specific and nonspecific antisera. After har-identity) with the basic/leucine zipper (bZIP) domain of
CREB. Moreover, many genes that are regulated by vesting the complexes with magnetic beads, crosslinks
were reversed. DNA was purified from the uncrosslinkedCREB can be repressed by induction of ICER and CREM
(Laoide et al., 1993; Molina et al., 1993; Bodor et al., complexes and PCR performed with primers for the WXY
box and for the downstream region, exon 3 of HLA-1996; Tinti et al., 1996). To determine if ICER can repress
MHC class II expression, an ICER expression vector DRA a. A PCR product for the WXY box of the class II
promoter was obtained when antibodies to CREB or towas cotransfected with two WXY-dependent reporter
constructs into the MHC class II positive human B-cell RFX5 (a subunit of the RFX complex, acting as a positive
control) were used in the immunoprecipitation (Figureline Raji. ICER expression resulted in almost total repres-
sion of MHC class II expression (Figure 5). These data 6A). In contrast, chromatin immunoprecipitation reac-
tions performed with either no primary antisera, antibod-showed that ICER was capable of repressing transcrip-
tion from MHC class II promoters and further support ies against CREB family members ATF-1, ATF-2, ATF-3,
or antibodies against chloramphenicol acetyltransfer-the conclusion that CREB is the X2 factor required for
MHC class II expression. ase, resulted in no PCR products (Figure 6A). None of
the antibodies tested immunoprecipitated DNA specific
for exon 3 of the HLA-DRA, which is located greater thanCREB and RFX5 Proteins Are Associated
3 kb downstream of the WXY box sequences (Figure 6B),with the MHC Class II Promoter
indicating the specificity of the reaction. These reactionsIn vivo studies by Dedon et al. (1991a, 1991b) used
place CREB at the HLA-DRA X2 box in B cells andformaldehyde to covalently link proteins in close proxim-
demonstrate the role of CREB in MHC class II ex-ity to DNA. Recently, similar methodology has been used
to indicate accessible DNA by immunoprecipitation of pression.
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Figure 5. ICER Represses Transcription from the DRA MHC Class
II Promoter
(A) Raji B cells were cotransfected by electroporation (290 V, 960
mF) with 10 mg of the pDRCAT-WXY reporter construct and the
indicated amount of the ICER expression construct (pSG-ICER).
CAT levels were normalized to those obtained with reporter alone.
The average of at least three transfections and the standard error Figure 6. CREB and RFX5 Are Bound to the X Box In Vivo
are shown.
Chromatin immunoprecipitation assays were used to determine if(B) Raji cells were cotransfected with the indicated amount of pSG-
CREB was associated the HLA-DRA X2 box in vivo. Raji B cellsICER and 10 mg of the pgloCATwt reporter construct (Sloan et al.,
were treated with formaldehyde for 10 min to covalently link proteins1992), which contains the W-X-Y region of the DRA promoter in the
to associated DNA. Chromatin was isolated, sheared by sonication,context of the b-globin promoter.
and immunoprecipitations performed with the antibodies indicated.
Immune complexes were harvested with secondary antibodies
Discussion attached to magnetic beads. The beads were stringently washed
and crosslinks reversed as described in the Experimental Proce-
dures section. DNA was purified and used as a template for PCRThe finding in this report that CREB is the transcription
reactions with either primers for the WXY box (A) or for exon 3 (B)factor X2BP and functions in MHC class II regulation
of the HLA-DRA gene.
completes the identification of the major factors in-
volved in the regulation of MHC class II genes. Our
Additionally, CREB has been implicated in regulation ofanalysis provides both biochemical and biological evi-
MHC class I expression through a critical CRE sitedence to support this conclusion, including the in vivo
termed site a (Dey et al., 1992). Transgenic mouse stud-association of CREB with the class II promoter. As dis-
ies have shown that site a is critical for both HLA-B7cussed below, CREB's involvement in the regulation of
expression and for in vivo occupancy at multiple adja-MHC genes presents new levels of regulation of this
cent cis-elements (Kushida et al., 1997). CREB maysystem.
therefore facilitate stable synergistic interactions atThese observations also add MHC class II genes to
MHC class I promoters. Site a is also required for CIITA-a long list of genes regulated by CREB, which include
dependent enhanced class I expression (Gobin et al.,several in the immune system. CREB has been shown to
1997; Martin et al., 1997), suggesting the possibility thatplay a pivotal role in the regulation of the T cell receptor a
CREB-CIITA interactions may be important for MHCchain (Mayall et al., 1997). Analysis of transgenic mice
class I as well as class II expression. Thus, CREB'scarrying a dominant negative form of CREB expressed
involvement in MHC class II, TCR a, and potentially MHConly in T lymphocytes demonstrated that CREB is re-
quired for maturation of thymocytes (Barton et al., 1996). class I gene expression suggests that CREB plays a
Immunity
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major role in the regulation of antigen processing and nuclear hormone receptor interactions, are important
for CIITA function (Brown et al., 1998). One of theseantigen recognition.
One test of the effectiveness of CREB in vivo is to domains may be important for interactions with CREB.
The inability to easily detect CIITA binding to the Xexamine the effects of MHC class II expression and
immune responsiveness in a mouse deficient in CREB box in vitro might indicate that additional factors are
required. One possibility is that the CREB binding pro-activity. Although mice with a targeted mutation of
CREBa and CREBD isoforms are deficient in the forma- tein, CBP, is required. Recently, two reports have found
that overexpression of CBP synergistically activatestion of long-term neurological memory, they otherwise
appear normal (Bourtchuladze et al., 1994). However, CIITA-dependent expression from MHC class II promot-
ers, and that this activation was dependent on the acti-these mice show upregulation of the b isoform of CREB
(Blendy et al., 1996), possibly explaining why these mice vation domain of CIITA (Kretsovali et al., 1998; Fontes
et al., 1999). CBP can also interact with CREB throughwere not reported to be immunocompromised. Evalua-
tion of a complete CREB deficiency on MHC class II a kinase inducible domain (KID) that must be phosphory-
lated at a specific serine residue (Gonzalez and Mont-expression is not possible because a homozygous null
mutation in all CREB isoforms results in perinatal death miny, 1989; Chrivia et al., 1993). The majority of CREB
in Raji cells is not phosphorylated (data not shown);(Blendy et al., 1996). To overcome this limitation and
provide in vivo data, we employed the recently devel- however, the multiple banding pattern observed with
X2BP (Hasegawa and Boss, 1991; Moreno et al., 1995)oped chromatin immunoprecipitation assays (Kuo et al.,
1998). This technique provides strong in vivo evidence and the PKA phosphorylation experiment presented
suggest that some CREB is phosphorylated. If CREB isthat a factor is indeed bound at the site previously char-
acterized in vitro. In the case of the X2 box, where poten- phosphorylated at Ser119, then this would allow CBP
to bind and potentially interact with CIITA. Because CBPtially many family members could bind in vitro, only
CREB was found to produce a strong signal. The inter- has an intrinsic histone acetylase activity, this event
could be important for the induction of class II by inter-pretation of the results were supported by the positive
control antiserum, anti-RFX5, which was expected to feron-g and the stabilization of the in vivo footprint at
the X box that is observed after interferon-g treatmentbind to the X1 portion of the X box. Also important in
this assay was the demonstration that not all DNAs were (Westerheide et al., 1997; Wright et al., 1998).
The finding that CREB is involved in class II expressionamplified, as a portion of the HLA-DRA gene just 3 kb
downstream of the promoter was not precipitated in suggests additional modes of regulation of MHC class II
genes. Both PKC and PKA activation can affect CREB'sthese assays.
There are several mechanisms by which CREB may transactivation potential (Gonzalez and Montminy, 1989;
Xie and Rothstein, 1995; Hardingham et al., 1997). MHCparticipate in controlling the expression of MHC class
II genes. In the simplest model, CREB functions in a genes are in fact upregulated through PKC-dependent
mechanisms, following the crosslinking of surface Ig (Xiemanner that allows the assembly of the RFX-CREB-
NF-Y complex on DNA. Recent site specific crosslinking et al., 1996). The current results suggest the interesting
possibility that this could be due to changes in CREBanalysis of the X box region showed that CREB is in
close proximity to the first three nucleotides of the X2 phosphorylation, which may result in the recruitment of
CBP and/or the more efficient recruitment of CIITA. PKAbox (Westerheide and Boss, unpublished data). Juxta-
posed to the 59 side of these basepairs are contact stimulation of CREB activity, as a result of increases
in cAMP levels, could also affect MHC class II genenucleotides for one of the RFX subunits. It is important
to stress that only the DRA X box region independently expression. However, in contrast to other systems, in
which CREB phosphorylation by PKA enhances tran-binds RFX or CREB in vitro. However, an RFX-CREB-X
box complex can be formed on all X boxes (Louis-Plence scriptional activity, increases in cAMP levels have been
shown to reduce surface class II expression (Ivashkivet al., 1997). Thus, it is possible that CREB and this RFX
subunit make protein-protein contacts at this site that and Glimcher, 1991; Roper et al., 1994). This contradic-
tion suggests that increases in cAMP levels must re-could be important in complex assembly. Recent obser-
vations for the class I genes, where site a binds a CREB/ press class II by an alternative mechanism(s). It is in-
triguing to speculate that the induction of ICER byATF-1 and RFX, suggest that the same may be true for
class I MHC genes (Gobin et al., 1997, 1998; Martin et increases in cAMP levels (Molina et al., 1993; Bodor et
al., 1996) leads to the repression of MHC class II genesal., 1997). Because simple binding of the class II-specific
DNA binding proteins is not sufficient for expression, as suggested by the repression of the class II reporter
constructs in the current study. In support of this hypoth-the CREB-RFX complex may serve as a docking site for
CIITA. While the minimal X box sequence is sufficient esis, prostaglandin E2 (PGE2) treatment of resting B cells
was observed to repress MHC class II expressionto promote CIITA-dependent expression (Riley et al.,
1995), direct physical interactions between CIITA and through a cAMP-mediated mechanism (Roper et al.,
1994). In this system, PGE2 treatment of resting B cellsthe X box factors have not been observed in mammalian
cells. A weak interaction between RFX5 and CIITA was induced regulatory proteins that have a similar molecu-
lar weight and isoelectric point as ICER (Roper et al.,observed in a yeast two-hybrid assay (Scholl et al.,
1997). However, CIITA contains multiple domains that 1994). The observation that ICER can repress class II
expression may be useful in developing or testing novelcould be involved in many protein-protein interactions.
Recently, we observed that mutation in leucine charged therapeutic approaches that induce cAMP-mediated
signal transduction cascades for treatment of autoim-domains that conform to the sequence LXXLL consen-
sus, which are similar to those required for CBP and mune diseases. Alternatively, increases in cAMP levels
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with 1.0 M Tris-HCl (pH 8.8). The EMSA supershift grade anti-may titrate the available CBP from the MHC class II
ATF-1, anti-ATF-2, and anti-ATF-3 antibodies were purchased frompromoters. This hypothesis is supported by recent ex-
Santa Cruz Biotechnologies (Santa Cruz, CA).periments in which glucocorticoid reduction in MHC
class II expression was reversed by the overexpression
EMSAsof CBP (Fontes et al., 1999). Another mechanism may
EMSAs were performed as previously described (Moreno et al.,
involve the binding of CBP by phospho-CREB in a man- 1995; Louis-Plence et al., 1997).
ner that is unfavorable for CIITA stimulation of MHC
class II transcription. Now that the key DNA binding RT-PCR and PCR
factors for class II promoters have been identified, ex- To determine if the K305 polymorphism was present in Raji cells,
RT-PCR was performed using the 59 primer CACATTAGCCCAGGTAperiments addressing these models can be performed.
TCTATGCC and either the 39 primer CCTCAATCAATGTCTTGTTTTG
ATTTTC, which corresponds to glutamic acid at CREB codon 305,Experimental Procedures
or the 39 primer CCTCAATCAATGTCTTGTTTTGATTTTT, which cor-
responds to lysine at CREB codon 305. Primers used to monitorCells
CIITA mRNA levels were (59 primer) GATTCCTACACAATGCGTTGCRaji B cells were grown in RPMI (Life Technologies, Inc.) supple-
CTGGCTC and (39 primer) TGGTGGGGACAAACTGGATGGG. Posi-mented with 5% fetal bovine serum (Sigma, Inc.), 5% calf serum
tive control reactions were performed using primers to glyceralde-(HyClone, Inc.), 2 mM L-glutamine, and 100 U/ml penicillin/strepto-
hyde-3-phosphate dehydrogenase (GAPDH) (59 primer) CCATGGmycin. F9 cells were grown in DMEM medium (Mediatech, Inc.)
GGAAGGTGAAGGTCGGAGTC and (39 primer) GAGGAGTGGGTGTsupplemented with 10% fetal bovine serum (Sigma, Inc.), 2 mM
CGCTGTTGAAGTC. Primers for the WXY box of the class II promoterL-glutamine (Life Technologies, Inc.), 100 U/ml penicillin/streptomy-
were (59 primer) GATCTCTTGTGTCCTGGACCCTTTGCAAGAACcin (Life Technologies, Inc.), 1 mM sodium pyruvate (Life Technolo-
CCT and (39 primer) CCCAATTACTCTTTGGCCAATCAGAAAAATgies, Inc.), and 7.5% sodium bicarbonate (Life Technologies, Inc.).
ATTTTG. Primers for exon 3 of HLA DRA were (59 primer) GAGTTTTissue culture plates for F9 cells were pretreated with 0.5% gelatin
GATGCTCCAAGCCCTCTCCCA and (39 primer) CAGAGGCCCCCTfor 2 hr at 48C, rinsed three times with sterile dH2O, and dried.
GCGTTCTGCTGCATT.
X2BP Purification
Transient TransfectionsX2BP was purified as previously described (Moreno et al., 1995)
F9 were cotransfected by electroporation (300 V, 960 mF). Raji Bwith the addition of a magnetic bead DNA affinity chromatography
cells were also cotransfected by electroporation (290 V, 960 mF).step. A magnetic bead DNA affinity column was synthesized by
The total amount of DNA per transfection was equalized by additionusing X box oligonucleotides described previously (Hasegawa et
of pUC18 plasmid DNA. Cells were harvested 48 hr posttransfection.al., 1991), DRAX5 (TTGCAAGAACCCTTCCCCTAGCAACAGATGCG
CAT levels were determined by ELISA (Boehringer Mannheim, Inc.,TCATCTCAAAATATTTTTCTGA), and its complementary sequence
Indianapolis, IN) and normalized for transfection efficiency by lucif-DRAX3 (ATCAGAAAAATATTTTGAGATGACGCATCTGTTGCTAGG
erase assay (Promega, Madison, WI). All transient assays were per-GGAAGGGTTCTTGCA). A biotinylated version of the DRAX3 oligo
formed at least three times as complete sets. A representative set(BIODRAX3) was also synthesized (Operon Technologies, Inc, Ala-
is presented.meda, CA). Oligonucleotides were gel-purified, annealed, phosphor-
ylated, and blunt end ligated at 168C. Double-stranded, biotinylated
DRAX oligonucleotides were added to the ligations at a 1:5 ratio Chromatin Immunoprecipitation
(biotinylated:unbiotinylated double-stranded DNA) 2 hr after the initi- Chromatin Immunoprecipitation (ChIP) assays were performed es-
ation of the ligation reaction. Biotinylated, double-stranded DRAX sentially as described in a procedure obtained from the P. Farnham
multimers were bound to M-280 streptavidin magnetic beads (Dynal, laboratory (University of Wisconsin). Raji B cells were exposed to
Inc., Lake Success, NY) according to the manufacturer's instruc- formaldehyde at a final concentration of 1% added directly to the
tions. Affinity-purified X2BP was bound to the magnetic affinity col- tissue culture medium. Cells were pelleted after 10 min of formalde-
umn in Binding Buffer (100 mM NaCl, 12% glycerol, 12 mM HEPES hyde exposure, resuspended in phosphate-buffered saline, and re-
[pH 7.9], 5 mM MgCl2, 0.24 mM EDTA, 0.24 mM EGTA, 2 mM DTT, pelleted. Cells were lysed in lysis buffer (5 mM PIPES [pH 8.0], 85
and 0.1% NP-40) for 30 min at 48C. Bound proteins were washed mM KCl, and 0.5% NP40 containing protease inhibitors [1 mM
three times with Binding Buffer and eluted in 600 mM NaCl Binding PMSF, 1 mg/ml leupeptin, and 1 mg/ml aprotinin]) and incubated on
Buffer. Sequencing of X2BP was carried out on peptides derived ice for 5 min. Nuclei were pelleted and lysed in nuclei lysis buffer
from bands isolated by SDS-PAGE of purified X2BP. Peptide digests (50 mM Tris-HCl [pH 8.1], 10 mM EDTA, and 1% SDS), containing
and internal amino acid microsequencing were performed at the protease inhibitors. Lysed nuclei were sonicated using a microtip
Emory Microchemical Facility, Winship Cancer Center, Emory Uni- until the average DNA fragment was approximately 600 base pairs.
versity School of Medicine. Mass spectrometry analysis was per- Chromatin samples were diluted 1:10 with IP dilution buffer (0.01%
formed at the W. M. Keck Foundation Biotechnology Resource Lab- SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl [pH 8.1],
oratory, Yale University. and 167 mM NaCl) containing protease inhibitors and 50 mg/ml of
yeast tRNA 20 mg/ml salmon sperm DNA. Immunoprecipitations
were performed at 48C for 2 hr with 5 mg of primary antibody (anti-Antisera
CREB rabbit polyclonal antisera was raised commercially (Rockland, ATF-1, anti-ATF-2, and anti-ATF-3 antibodies were purchased from
Santa Cruz Biotechnologies [Santa Cruz, Ca]. Immune complexesInc.) by injection of keyhole limpet hemocyanin (KLH)-linked peptide
antigen. Polyclonal anti-human CREB antisera was raised to a single were harvested with secondary antibodies linked to magnetic beads
(Dynal, Lake Success, NY). Immune complexes were washed threechemically synthesized peptide spanning amino acids 5±45 in the
N-terminal domain of human CREB (Figure 2). Peptides were cross- times for a period of 10 min with the following buffers: IP dilution
buffer, dialysis buffer (2 mM EDTA, 50 mM Tris-HCl [pH 8.1], andlinked to KLH with 0.2% glutaraldehyde as described (Coligan et
al., 1991) and used to immunize rabbits. Rabbit anti-RFX5 antisera 0.2% sarkosyl), TSE-500 (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20 mM Tris-HCl [pH 8.1], and 500 mM NaCl), and IP wash bufferwas previously described (Moreno et al., 1997). RFX5, CREB, and
CAT antisera were purified over HiTrap A columns (Pharmacia, Pis- (100 mM Tris-HCl [pH 8.1], 500 mM NaCl, 1% NP40, and 1% deoxy-
cholic acid), followed by a final wash with TE (10 mM Tris-HCl [pHcataway, NJ) and concentrated by affinity chromatography to the
peptides that were used to generate the sera. Peptides were linked 8.0] and 1 mM EDTA). Immune complexes were disrupted with elu-
tion buffer (50 mM NaHCO3 and 1% SDS) and covalent links reversedto a 1 ml NHS column as described by the manufacturer (Pharmacia,
Piscataway, NJ). The antisera were loaded onto the column in phos- by addition of NaCl to a final concentration of 300 mM and heating
to 658C for 6 hr. DNA was ethanol precipitated and further purified byphate-buffered saline, washed in the same buffer containing 500 mM
NaCl, eluted in 100 mM glycine (pH 3.0), and immediately neutralized proteinase K digestion, phenol/chloroform extraction, and ethanol
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precipitated. DNA pellets were dissolved in 30 ml water and 3 ml (1984). Immune interferon activates multiple class II major histocom-
patibility complex genes and the associated invariant chain gene inused as template for PCR reactions.
human endothelial cells and dermal fibroblasts. Proc. Natl. Acad.
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